← Back to Search

Corticosteroid

Steroid Injections for Trigger Finger

N/A

Recruiting

Led By Kevin Zuo, MD, MASc

Research Sponsored by Kevin Zuo

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Have a diagnosis of trigger finger (can be any of the 5 digits)

Be 18 years of age or older

Must not have

Decline to obtain a CSI for trigger finger management

Receiving multiple CSI for trigger finger management at the appointment

Timeline

Screening 3 weeks

Treatment Varies

Follow Up measured at 0 hours post-injection

Awards & highlights

No Placebo-Only Group

Summary

This trial compares the pain associated with steroid injections for trigger finger when given from the front/palm side of the hand versus the back/dorsal side. The study aims to determine if injections from the

Who is the study for?

This trial is for individuals with trigger finger, a condition where a finger gets stuck in a bent position. Participants should be those who haven't had relief from other treatments and are suitable candidates for steroid injections.

What is being tested?

The study compares two methods of administering steroid injections to treat trigger finger: one through the back/dorsal side of the hand, which may be less painful, and the standard front/palm side injection.

What are the potential side effects?

Potential side effects include pain at the injection site, possible infection, temporary numbness or tingling in the injected area, and rarely tendon damage.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with trigger finger.

Select...

I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I choose not to get a corticosteroid injection for my trigger finger.

Select...

I am getting several steroid injections for my trigger finger.

Select...

I have had surgery or CSI on the affected finger.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ measured at 0 hours, 4 hours, and 24 hours post-injection

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~measured at 0 hours, 4 hours, and 24 hours post-injection

This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at 0 hours, 4 hours, and 24 hours post-injection for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Numerical Rating Scale (NRS) - Pain

Short-Form McGill Pain Questionnaire (SFMPQ) - Present Pain Intensity (PPI)

Visual Analogue Scale (VAS) - Pain

Secondary study objectives

Sensory Assessment - Light Touch

Sensory Assessment - Pain

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Dorsal Webspace ApproachExperimental Treatment1 Intervention

A dorsal approach involves passing the needle with a 1:1 triamcinolone and lidocaine mixture in the dorsal webspace skin aiming just palmar to the proximal phalanx bone such that the needle is directed into the flexor tendon sheath at the A1 annular pulley.

Group II: Palmar ApproachActive Control1 Intervention

Standard approach for injecting the 1:1 triamcinolone and lidocaine mixture involves the needle passing through the cutaneous and subcutaneous layers of the palmar skin surface and into the flexor tendon sheath at the A1 annular pulley.

0 / 5Eligibility criteria met